Lesley Taylor

2.1k total citations · 2 hit papers
13 papers, 1.6k citations indexed

About

Lesley Taylor is a scholar working on Psychiatry and Mental health, Pharmacology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lesley Taylor has authored 13 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lesley Taylor's work include Cannabis and Cannabinoid Research (5 papers), Bipolar Disorder and Treatment (4 papers) and Infrared Thermography in Medicine (3 papers). Lesley Taylor is often cited by papers focused on Cannabis and Cannabinoid Research (5 papers), Bipolar Disorder and Treatment (4 papers) and Infrared Thermography in Medicine (3 papers). Lesley Taylor collaborates with scholars based in United Kingdom and United States. Lesley Taylor's co-authors include Gilmour Morrison, Bola Tayo, Kevan C. Herold, Jeffrey A. Bluestone, David M. Harlan, David Donaldson, Danlin Xu, William Hagopian, Stephen E. Gitelman and Robert A. Zivin and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Clinical Pharmacokinetics.

In The Last Decade

Lesley Taylor

13 papers receiving 1.5k citations

Hit Papers

Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes... 2002 2026 2010 2018 2002 2018 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus
    2002 903 citations Kevan C. Herold, William Hagopian et al. New England Journal of Medicine profile →
  2. A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
    2018 341 citations Lesley Taylor, Barry E. Gidal et al. CNS Drugs profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lesley Taylor United Kingdom 10 753 643 623 521 358 13 1.6k
J. Satoh Japan 16 275 0.4× 241 0.4× 261 0.4× 113 0.2× 186 0.5× 32 1.0k
Pierre Corvol France 9 351 0.5× 915 1.4× 261 0.4× 291 0.6× 31 0.1× 9 1.8k
Bert Toivola United States 13 434 0.6× 596 0.9× 484 0.8× 30 0.1× 241 0.7× 20 1.2k
Stéphane Lobbens France 21 377 0.5× 225 0.3× 226 0.4× 83 0.2× 83 0.2× 29 1.3k
Natascha Potoczna Switzerland 16 247 0.3× 153 0.2× 468 0.8× 63 0.1× 140 0.4× 24 1.4k
Běla Bendlová Czechia 26 406 0.5× 888 1.4× 378 0.6× 45 0.1× 64 0.2× 118 2.1k
Emad Siddiqui United Kingdom 25 206 0.3× 466 0.7× 310 0.5× 106 0.2× 15 0.0× 75 2.6k
Josefa Ros Velasco Spain 25 53 0.1× 173 0.3× 609 1.0× 438 0.8× 84 0.2× 64 2.0k
Sigri Beckers Belgium 19 299 0.4× 158 0.2× 140 0.2× 79 0.2× 75 0.2× 47 1.2k
R. Eissele Germany 20 158 0.2× 562 0.9× 723 1.2× 71 0.1× 47 0.1× 54 1.5k

Countries citing papers authored by Lesley Taylor

Since Specialization
Citations

This map shows the geographic impact of Lesley Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lesley Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lesley Taylor more than expected).

Fields of papers citing papers by Lesley Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lesley Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lesley Taylor. The network helps show where Lesley Taylor may publish in the future.

Co-authorship network of co-authors of Lesley Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Lesley Taylor. A scholar is included among the top collaborators of Lesley Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lesley Taylor. Lesley Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Taylor, Lesley, Julie C. Crockett, Bola Tayo, Daniel Checketts, & Kenneth W. Sommerville. (2020). Abrupt withdrawal of cannabidiol (CBD): A randomized trial. Epilepsy & Behavior. 104(Pt A). 106938–106938. 37 indexed citations
2.
VanLandingham, Kevan, Julie C. Crockett, Lesley Taylor, & Gilmour Morrison. (2020). A Phase 2, Double‐Blind, Placebo‐Controlled Trial to Investigate Potential Drug‐Drug Interactions Between Cannabidiol and Clobazam. The Journal of Clinical Pharmacology. 60(10). 1304–1313. 29 indexed citations
3.
Tayo, Bola, Lesley Taylor, Farhad Sahebkar, & Gilmour Morrison. (2019). A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment. Clinical Pharmacokinetics. 59(6). 747–755. 46 indexed citations
4.
Taylor, Lesley, Julie C. Crockett, Bola Tayo, & Gilmour Morrison. (2019). A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment. The Journal of Clinical Pharmacology. 59(8). 1110–1119. 83 indexed citations
5.
Taylor, Lesley, Barry E. Gidal, Graham Blakey, Bola Tayo, & Gilmour Morrison. (2018). A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects. CNS Drugs. 32(11). 1053–1067. 341 indexed citations breakdown →
6.
Herold, Kevan C. & Lesley Taylor. (2003). Treatment of Type 1 Diabetes With Anti-CD3 Monoclonal Antibody: Induction of Immune Regulation?. Immunologic Research. 28(2). 141–150. 20 indexed citations
7.
Herold, Kevan C., William Hagopian, Julie Auger, et al.. (2002). Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus. New England Journal of Medicine. 346(22). 1692–1698. 903 indexed citations breakdown →
8.
Klimiuk, P S, K Illingworth, Rodney Gush, et al.. (1992). A double blind placebo controlled trial of recombinant tissue plasminogen activator in the treatment of digital ischemia in systemic sclerosis.. PubMed. 19(5). 716–20. 10 indexed citations
9.
Stoner, H. B., Lesley Taylor, & R W Marcuson. (1989). The value of skin temperature measurements in forecasting the healing of a below-knee amputation for end-stage ischaemia of the leg in peripheral vascular disease. European Journal of Vascular Surgery. 3(4). 355–361. 6 indexed citations
10.
Mitchell, William, Peter Winocour, Rodney Gush, et al.. (1989). SKIN BLOOD FLOW AND LIMITED JOINT MOBILITY IN INSULIN-DEPENDENT DIABETES MELLITUS. Lara D. Veeken. 28(3). 195–200. 11 indexed citations
11.
Winocour, Peter, William Mitchell, Rodney Gush, Lesley Taylor, & Rose Baker. (1988). Altered Hand Skin Blood Flow in Type 1 (Insulin‐dependent) Diabetes Mellitus. Diabetic Medicine. 5(9). 861–866. 9 indexed citations
12.
Grennan, D M, et al.. (1984). A comparative evaluation of thermography and scintigraphy in the assessment of sacroiliitis. International Journal of Nuclear Medicine and Biology. 11(1). 42–45. 3 indexed citations
13.
Taylor, Lesley, et al.. (1976). α-1-Antitrypsin Deficiency in Liver Disease: The Extent of the Problem. Gastroenterology. 71(4). 646–651. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Satoh Breakdown of academic impact, for papers by Pierre Corvol Breakdown of academic impact, for papers by Bert Toivola Breakdown of academic impact, for papers by Stéphane Lobbens Breakdown of academic impact, for papers by Natascha Potoczna Breakdown of academic impact, for papers by Běla Bendlová Breakdown of academic impact, for papers by Emad Siddiqui Breakdown of academic impact, for papers by Josefa Ros Velasco Breakdown of academic impact, for papers by Sigri Beckers Breakdown of academic impact, for papers by R. Eissele
Rankless by CCL
2026